Medinet Co Investor
Cancer immuno-cell therapy is an advanced medical practice.
Technology:
Regenerative Medicine
Industry:
Investor
Headquarters:
Kahoku, Miyagi, Japan
Founded Date:
1995-01-01
Employees Number:
51-100
Funding Status:
IPO
Investor Type:
Corporate Venture Capital
Investors Number:
1
Total Funding:
$4,267,613
Estimated Revenue:
$1M to $10M
Last Funding Date:
2015-09-29
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership